Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Up0.89% Nasdaq Up1.26%

Elan Corporation, plc (ELN)

-NYSE

11.61 Up 0.01(0.09%) 4:02PM EDT|After Hours : 11.57 Down 0.04 (0.34%) 4:24PM EDT - Nasdaq Real Time Price

Add to Portfolio
ProfileGet Profile for:
Elan Corporation, plc
Treasury Building
Lower Grand Canal Street
Dublin, 2
Ireland - Map
Phone: 353 1 709 4000
Fax: 353 1 709 4700
Website: http://www.elan.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Delivery
Full Time Employees:245

Business Summary 

Elan Corporation, plc operates as a biotechnology company in the United States, Ireland, and internationally. The company primarily develops ELND005, an orally bioavailable small molecule in Phase II clinical trial being investigated for multiple neuropsychiatric indications on the basis of its proposed dual mechanism of action, which includes b-amyloid anti-aggregation and regulation of brain myo-inositol levels. It also develops ELND005 as an adjunctive maintenance treatment in patients with Bipolar I Disorder to delay the time to occurrence of mood episodes; and for the treatment of agitation/aggression in patients with moderate to severe Alzheimer’s disease. Elan Corporation, plc was founded in 1969 and is headquartered in Dublin, Ireland.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Elan Corporation, plc

Key Executives 
 PayExercised
Mr. G. Kelly Martin , 54
Chief Exec. Officer and Exec. Director
N/AN/A
Mr. Hans Peter Hasler , 57
Chief Operating Officer
N/AN/A
Mr. William F. Daniel , 61
Exec. VP and Company Sec.
N/AN/A
Mr. Nigel Clerkin , 39
Chief Financial Officer and Exec. VP
N/AN/A
Ms. Grainne McAleese , 33
Principal Accounting Officer and Group Controller
N/AN/A
Amounts are as of Dec 30, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.